• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全外显子组测序鉴定 MRVI1 为神经纤维瘤病 1 型伴发烟雾病的易感基因。

Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1.

机构信息

Dipartimento della Donna, del Bambino e di Chirurgia Generale e Specialistica, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy.

Dipartimento di Medicina di Precisione, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy.

出版信息

PLoS One. 2018 Jul 12;13(7):e0200446. doi: 10.1371/journal.pone.0200446. eCollection 2018.

DOI:10.1371/journal.pone.0200446
PMID:30001348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6042724/
Abstract

BACKGROUND AND PURPOSE

Moyamoya angiopathy is a progressive cerebral vasculopathy. The p.R4810K substitution in RNF213 has previously been linked to moyamoya disease in Asian populations. When associated with other medical conditions, such as neurofibromatosis type 1, this vasculopathy is frequently reported as moyamoya syndrome. Intriguingly, most cases of moyamoya-complicated neurofibromatosis type 1 have been described in Caucasians, inverting the population ratio observed in Asians, although prevalence of neurofibromatosis type 1 is constant worldwide. Our aim was to investigate whether, among Caucasians, additive genetic factors may contribute to the occurrence of moyamoya in neurofibromatosis type 1.

METHODS

Whole exome sequencing was carried out on an Italian family with moyamoya-complicated neurofibromatosis type 1 to identify putative genetic modifiers independent of the NF1 locus and potentially involved in moyamoya pathogenesis. Results were validated in an unrelated family of German ancestry.

RESULTS

We identified the p.P186S substitution (rs35857561) in MRVI1 that segregated with moyamoya syndrome in both the Italian and German family.

CONCLUSIONS

The rs35857561 polymorphism in MRVI1 may be a genetic susceptibility factor for moyamoya in European patients with neurofibromatosis type 1. MRVI1 is a functional partner of ITPR1, PRKG1 and GUCY1A3, which are involved in response to nitric oxide. Mutations in GUCY1A3 have been recently linked to a recessive syndromic form of moyamoya with esophageal achalasia.

摘要

背景与目的

烟雾病是一种进行性的脑血管病。RNF213 中的 p.R4810K 取代先前与亚洲人群的烟雾病有关。当与其他医学状况(如神经纤维瘤病 1 型)相关联时,这种血管病常被报告为烟雾病综合征。有趣的是,大多数伴有神经纤维瘤病 1 型的烟雾病病例发生在白种人群中,与亚洲人群观察到的比例相反,尽管神经纤维瘤病 1 型的患病率在全球范围内是恒定的。我们的目的是研究在白种人群中,附加遗传因素是否可能导致神经纤维瘤病 1 型发生烟雾病。

方法

对一个意大利伴有神经纤维瘤病 1 型合并烟雾病的家系进行全外显子组测序,以鉴定与 NF1 基因座无关且可能参与烟雾病发病机制的潜在遗传修饰因子。结果在一个具有德国血统的无关家系中得到了验证。

结果

我们鉴定出了 MRVI1 中的 p.P186S 取代(rs35857561),该取代在意大利和德国家系中与烟雾病综合征共分离。

结论

MRVI1 中的 rs35857561 多态性可能是欧洲神经纤维瘤病 1 型患者发生烟雾病的遗传易感因素。MRVI1 是 ITPR1、PRKG1 和 GUCY1A3 的功能伴侣,这些基因参与对一氧化氮的反应。GUCY1A3 的突变最近与一种隐性综合征形式的烟雾病伴食管失弛缓症有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ae/6042724/3458fea92202/pone.0200446.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ae/6042724/13712d903001/pone.0200446.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ae/6042724/52a1a0b897a8/pone.0200446.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ae/6042724/3458fea92202/pone.0200446.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ae/6042724/13712d903001/pone.0200446.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ae/6042724/52a1a0b897a8/pone.0200446.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ae/6042724/3458fea92202/pone.0200446.g003.jpg

相似文献

1
Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1.全外显子组测序鉴定 MRVI1 为神经纤维瘤病 1 型伴发烟雾病的易感基因。
PLoS One. 2018 Jul 12;13(7):e0200446. doi: 10.1371/journal.pone.0200446. eCollection 2018.
2
Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1.1型神经纤维瘤病患者中烟雾综合征与RNF213基因c.14576G>A变异之间的关联。
J Neurosurg Pediatr. 2016 Jun;17(6):717-22. doi: 10.3171/2015.10.PEDS15537. Epub 2016 Feb 5.
3
Whole-exome sequencing reveals the genetic causes and modifiers of moyamoya syndrome.全外显子组测序揭示了烟雾病的遗传病因和修饰因子。
Sci Rep. 2024 Oct 4;14(1):22720. doi: 10.1038/s41598-024-72043-5.
4
Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience.1型神经纤维瘤病患儿的烟雾综合征:意大利-法国的经验。
Am J Med Genet A. 2017 Jun;173(6):1521-1530. doi: 10.1002/ajmg.a.38212. Epub 2017 Apr 19.
5
Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing.通过外显子组测序分析大型多民族烟雾病患者群体的疾病变异图谱
G3 (Bethesda). 2015 Nov 3;6(1):41-9. doi: 10.1534/g3.115.020321.
6
RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.RNF213 作为中国烟雾病患者的主要易感基因及其临床相关性。
J Neurosurg. 2017 Apr;126(4):1106-1113. doi: 10.3171/2016.2.JNS152173. Epub 2016 Apr 29.
7
Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.RNF213基因多态性对烟雾病临床特征及长期预后的重要性。
J Neurosurg. 2016 May;124(5):1221-7. doi: 10.3171/2015.4.JNS142900. Epub 2015 Oct 2.
8
Clinical and Molecular Features of 5 European Multigenerational Families With Moyamoya Angiopathy.5 个欧洲多代家族烟雾病的临床和分子特征。
Stroke. 2019 Apr;50(4):789-796. doi: 10.1161/STROKEAHA.118.023972.
9
Rare and Low-Frequency Variants in RNF213 Confer Susceptibility to Moyamoya Syndrome Associated with Hyperthyroidism.RNF213基因中的罕见和低频变异赋予了与甲状腺功能亢进相关的烟雾病综合征易感性。
World Neurosurg. 2019 Jul;127:e460-e466. doi: 10.1016/j.wneu.2019.03.172. Epub 2019 Mar 25.
10
Moyamoya syndrome and neurofibromatosis type 1.烟雾病合并 1 型神经纤维瘤病。
Ital J Pediatr. 2014 Jun 21;40:59. doi: 10.1186/1824-7288-40-59.

引用本文的文献

1
Polysomnographic study in pediatric neurofibromatosis type 1.1型小儿神经纤维瘤病的多导睡眠图研究
Front Neurol. 2023 Jul 18;14:1213430. doi: 10.3389/fneur.2023.1213430. eCollection 2023.
2
Novel Functional Features of cGMP Substrate Proteins IRAG1 and IRAG2.cGMP 底物蛋白 IRAG1 和 IRAG2 的新功能特征。
Int J Mol Sci. 2023 Jun 7;24(12):9837. doi: 10.3390/ijms24129837.
3
Moyamoya Vasculopathy in Neurofibromatosis Type 1 Pediatric Patients: The Role of Rare Variants of .1型神经纤维瘤病儿科患者的烟雾病血管病变:……罕见变异的作用

本文引用的文献

1
Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.通过全基因组关联研究发现的烟雾病新易感性基因座。
Stroke. 2018 Jan;49(1):11-18. doi: 10.1161/STROKEAHA.117.017430.
2
Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians.包含RING指结构域的C末端区域中的罕见RNF213变体与高加索人的烟雾病血管病变相关。
Eur J Hum Genet. 2017 Aug;25(8):995-1003. doi: 10.1038/ejhg.2017.92. Epub 2017 Jun 21.
3
Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience.
Cancers (Basel). 2023 Mar 22;15(6):1916. doi: 10.3390/cancers15061916.
4
Neurofibromatosis Type 1: Pediatric Aspects and Review of Genotype-Phenotype Correlations.1型神经纤维瘤病:儿科方面及基因型-表型相关性综述
Cancers (Basel). 2023 Feb 14;15(4):1217. doi: 10.3390/cancers15041217.
5
Monogenic Causes in Familial Stroke Across Intracerebral Hemorrhage and Ischemic Stroke Subtypes Identified by Whole-Exome Sequencing.全外显子组测序鉴定的脑内出血和缺血性卒中亚型家族性卒中的单基因病因。
Cell Mol Neurobiol. 2023 Aug;43(6):2769-2783. doi: 10.1007/s10571-022-01315-3. Epub 2022 Dec 29.
6
The infertile individual analysis based on whole-exome sequencing in chinese multi-ethnic groups.基于全外显子组测序的中国多民族群体不育个体分析。
Genes Genomics. 2023 Apr;45(4):531-542. doi: 10.1007/s13258-022-01307-z. Epub 2022 Sep 17.
7
Identification of three hub genes related to the prognosis of idiopathic pulmonary fibrosis using bioinformatics analysis.使用生物信息学分析鉴定与特发性肺纤维化预后相关的三个枢纽基因。
Int J Med Sci. 2022 Aug 15;19(9):1417-1429. doi: 10.7150/ijms.73305. eCollection 2022.
8
Mystery(n) Phenotypic Presentation in Europeans: Report of Three Further Novel Missense Variants Leading to Severe Syndromic Forms of Moyamoya Angiopathy and Literature Review.欧洲人表现出的神秘表型:报告三个新的错义变异导致严重的烟雾病综合征的血管病变,并进行文献复习。
Int J Mol Sci. 2022 Aug 11;23(16):8952. doi: 10.3390/ijms23168952.
9
Genotype-Phenotype Correlations in Neurofibromatosis Type 1: Identification of Novel and Recurrent Gene Variants and Correlations with Neurocognitive Phenotype.神经纤维瘤病 1 型的基因型-表型相关性:新的和反复出现的基因突变的鉴定及其与神经认知表型的相关性。
Genes (Basel). 2022 Jun 23;13(7):1130. doi: 10.3390/genes13071130.
10
Identification of novel proteins for lacunar stroke by integrating genome-wide association data and human brain proteomes.通过整合全基因组关联数据和人类大脑蛋白质组学,鉴定腔隙性卒中的新型蛋白。
BMC Med. 2022 Jun 23;20(1):211. doi: 10.1186/s12916-022-02408-y.
1型神经纤维瘤病患儿的烟雾综合征:意大利-法国的经验。
Am J Med Genet A. 2017 Jun;173(6):1521-1530. doi: 10.1002/ajmg.a.38212. Epub 2017 Apr 19.
4
Exome Sequencing Identified CCER2 as a Novel Candidate Gene for Moyamoya Disease.外显子组测序确定CCER2为烟雾病的一个新候选基因。
J Stroke Cerebrovasc Dis. 2017 Jan;26(1):150-161. doi: 10.1016/j.jstrokecerebrovasdis.2016.09.003. Epub 2016 Oct 4.
5
Neurofibromin is a novel regulator of Ras-induced reactive oxygen species production in mice and humans.神经纤维瘤蛋白是小鼠和人类中Ras诱导的活性氧生成的新型调节因子。
Free Radic Biol Med. 2016 Aug;97:212-222. doi: 10.1016/j.freeradbiomed.2016.06.002. Epub 2016 Jun 3.
6
Clinical characteristics and long-term outcomes of moyamoya syndrome associated with neurofibromatosis type 1.与1型神经纤维瘤病相关的烟雾综合征的临床特征及长期预后
J Clin Neurosci. 2015 Feb;22(2):286-90. doi: 10.1016/j.jocn.2014.05.046. Epub 2014 Oct 28.
7
A community-based resource for automatic exome variant-calling and annotation in Mendelian disorders.一个基于社区的用于孟德尔疾病中自动外显子组变异检测和注释的资源。
BMC Genomics. 2014;15 Suppl 3(Suppl 3):S5. doi: 10.1186/1471-2164-15-S3-S5. Epub 2014 May 6.
8
Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia.α1β1 可溶性鸟苷酸环化酶(一氧化氮主要受体)缺失导致烟雾病和贲门失弛缓症。
Am J Hum Genet. 2014 Mar 6;94(3):385-94. doi: 10.1016/j.ajhg.2014.01.018. Epub 2014 Feb 27.
9
Neurofibromatosis type 1 associated with moyamoya syndrome in children.儿童 1 型神经纤维瘤病合并烟雾病。
Pediatr Neurol. 2014 Jan;50(1):96-8. doi: 10.1016/j.pediatrneurol.2013.04.007. Epub 2013 Oct 23.
10
Nf1 loss and Ras hyperactivation in oligodendrocytes induce NOS-driven defects in myelin and vasculature.少突胶质细胞中 NF1 的缺失和 Ras 的过度激活导致髓鞘和血管的 NOS 驱动缺陷。
Cell Rep. 2013 Sep 26;4(6):1197-212. doi: 10.1016/j.celrep.2013.08.011. Epub 2013 Sep 12.